EFFECTS OF CANNABIDIOL IN HETEROZYGOUS NEUREGULIN 1 TRANSMEMBRANE DOMAIN MUTANT MICE

被引：0
|
作者：
Long, Leonora E. [1 ,2 ,3 ]
Chesworth, Rose [1 ,2 ]
Huang, Xu-Feng [1 ,4 ]
McGregor, Iain S. [5 ,6 ]
Arnold, Jonathon C. [1 ,6 ,7 ]
Karl, Tim [1 ,2 ,3 ]
机构：
[1] Schizophrenia Res Inst, Sydney, NSW, Australia
[2] Neurosci Res Australia, Sydney, NSW, Australia
[3] Univ New S Wales, Fac Med, Sydney, NSW, Australia
[4] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia
[5] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia
[6] Brain & Mind Res Inst, Sydney, NSW, Australia
[7] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2010年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：A53 / A53
页数：1
相关论文
共 50 条
  • [21] Heterozygous neuregulin-1 mutant mouse: Phenotypic relationship to schizophrenia
    O'Tuathaigh, C.
    Babovic, D. S.
    O'Sullivan, G. S.
    Croke, D. T.
    Harvey, R.
    Waddington, J. L.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 253 - 253
  • [22] Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol
    A. A. Boucher
    J. C. Arnold
    L. Duffy
    P. R. Schofield
    J. Micheau
    T. Karl
    Psychopharmacology, 2007, 192 : 325 - 336
  • [23] Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Δ9-tetrahydrocannabinol
    Boucher, A. A.
    Arnold, J. C.
    Duffy, L.
    Schofield, P. R.
    Micheau, J.
    Karl, T.
    PSYCHOPHARMACOLOGY, 2007, 192 (03) : 325 - 336
  • [24] A novel missense mutation in the transmembrane domain of neuregulin 1 is associated with schizophrenia
    Walss-Bass, Consuelo
    Liu, Wei
    Lew, Debbie F.
    Villegas, Ramon
    Montero, Patricia
    Dassori, Albana
    Leach, Robin J.
    Almasy, Laura
    Escamilla, Michael
    Raventos, Henriette
    BIOLOGICAL PSYCHIATRY, 2006, 60 (06) : 548 - 553
  • [25] The effects of preventative cannabidiol in a male neuregulin 1 mouse model of schizophrenia
    Visini, Gabriela
    Brown, Samara
    Weston-Green, Katrina
    Shannon Weickert, Cynthia
    Chesworth, Rose
    Karl, Tim
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [26] The response of neuregulin 1 mutant mice to acute restraint stress
    Chesworth, Rose
    Yulyaningsih, Ernie
    Cappas, Emily
    Arnold, Jonathon
    Sainsbury, Amanda
    Karl, Tim
    NEUROSCIENCE LETTERS, 2012, 515 (01) : 82 - 86
  • [27] Serotonin pharmacology of behavior in neuregulin-1 mutant mice and BDNF mutant mice: implications for schizophrenia
    den Buuse, M. V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 118 - 118
  • [28] Schizophrenia-related endophenotypes in heterozygous neuregulin-1 'knockout' mice
    O'Tuathaigh, C. M. P.
    Harte, M.
    O'Leary, C.
    O'Sullivan, G. J.
    Blau, C.
    Lai, D.
    Harvey, R. P.
    Tighe, O.
    Fagan, A. J.
    Kerskens, C.
    Reynolds, G. P.
    Waddington, J. L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2010, 31 (02) : 349 - 358
  • [29] Adolescent neuregulin 1 heterozygous mice display enhanced behavioural sensitivity to methamphetamine
    Spencer, Jarrah R.
    Darbyshire, Keturah M. E.
    Boucher, Aurelie A.
    Arnold, Jonathon C.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (02): : 376 - 381
  • [30] Neuregulin-1 immunoglobulin-like domain mutant mice: clozapine sensitivity and impaired latent inhibition
    Rimer, M
    Barrett, DW
    Maldonado, MA
    Vock, VM
    Gonzalez-Lima, F
    NEUROREPORT, 2005, 16 (03) : 271 - 275
12345